You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Lupin inches up after signing agreement

Capital Market 

rose 0.97% to Rs 768 at 14:48 IST on after the company signed an agreement with CSIR-and for conducting research.

The announcement was made during market hours today, 8 March 2018.

Meanwhile, the Sensex was up 329.59 points, or 1% to 33,362.68

On the BSE, 88,000 shares were traded in the counter so far, compared with average daily volumes of 1.06 lakh shares in the past one quarter. The stock had hit a high of Rs 770 and hit a low of Rs 750 so far during the day. The stock had hit a 52-week high of Rs 1,498.40 on 23 March 2017. The stock had hit a 52-week low of Rs 756.50 on 7 March 2018.

The large-cap company has equity capital of Rs 90.42 crore. Face value per share is Rs 2.

today announced the signing of an agreement with CSIR-(CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a monoclonal antibody therapeutic.

represent the most important product class, serving the highdemand treatment area of With an increasing demand for therapeutics and an ever-increasing pressure for manufacturing cost reduction with quality maintenance, the industry is showing keen interest in the development of

Through this research collaboration, CSIR-NCL and would collaboratively work towards the development of a novel continuous purification process for manufacturing a monoclonal antibody therapeutic (mAb).

Lupin's consolidated net profit plunged 64.98% to Rs 221.73 crore on 12.73% decline in total income to Rs 4004.63 crore in Q3 December 2017 over Q3 December 2016.

Lupin is a company developing and delivering a wide range of branded & generic formulations, products and (APIs) globally.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, March 08 2018. 15:02 IST